ATE419851T1 - Verwendung von riluzol zur behandlung multipler sklerose - Google Patents
Verwendung von riluzol zur behandlung multipler skleroseInfo
- Publication number
- ATE419851T1 ATE419851T1 AT05001476T AT05001476T ATE419851T1 AT E419851 T1 ATE419851 T1 AT E419851T1 AT 05001476 T AT05001476 T AT 05001476T AT 05001476 T AT05001476 T AT 05001476T AT E419851 T1 ATE419851 T1 AT E419851T1
- Authority
- AT
- Austria
- Prior art keywords
- riluzole
- multiple sclerosis
- treat multiple
- treat
- benzothiazolamine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99201788 | 1999-06-04 | ||
| US17432800P | 2000-01-04 | 2000-01-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE419851T1 true ATE419851T1 (de) | 2009-01-15 |
Family
ID=56290027
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05001476T ATE419851T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
| AT00939007T ATE287713T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00939007T ATE287713T1 (de) | 1999-06-04 | 2000-06-02 | Verwendung von riluzol zur behandlung multipler sklerose |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1187612B1 (de) |
| JP (1) | JP2003522121A (de) |
| AT (2) | ATE419851T1 (de) |
| AU (1) | AU777537B2 (de) |
| CA (1) | CA2375874A1 (de) |
| DE (1) | DE60017733T2 (de) |
| ES (1) | ES2235896T3 (de) |
| NZ (1) | NZ515685A (de) |
| PT (1) | PT1187612E (de) |
| SI (1) | SI1187612T1 (de) |
| WO (1) | WO2000074676A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000001376A2 (en) | 1998-07-02 | 2000-01-13 | Eisai Co., Ltd | Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| IL136687A0 (en) * | 2000-06-12 | 2001-06-14 | Mor Research Applic Ltd | Pharmaceutical composition for the treatment of multiple sclerosis |
| US20070244056A1 (en) * | 2004-03-03 | 2007-10-18 | Liat Hayardeny | Combination Therapy With Glatiramer Acetate and Riluzole |
| ITMI20061274A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Vettori nanoparticellari lipidici contenenti riluzolo e composizioni farmaceutiche che li contengono |
| EP2228054A1 (de) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Wässrige Riluzol-Suspensionen |
| WO2010113225A1 (en) * | 2009-03-30 | 2010-10-07 | Yutoku Pharmaceutical Industries Co., Ltd. | Riluzole-containing transdermal patch |
| WO2016081466A1 (en) * | 2014-11-21 | 2016-05-26 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual administration of riluzole |
| WO2016085998A1 (en) | 2014-11-26 | 2016-06-02 | Medicinova, Inc. | Combination of ibudilast and riluzole and methods of using same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
| WO1997015306A1 (en) * | 1995-10-25 | 1997-05-01 | Janssen Pharmaceutica N.V. | Infusions of neuroprotectants and perfluorochemicals |
| ATE248598T1 (de) * | 1995-11-15 | 2003-09-15 | Yamanouchi Pharma Co Ltd | Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate |
| US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
| IL119989A0 (en) * | 1997-01-10 | 1997-04-15 | Yeda Res & Dev | Pharmaceutical compositions for oral treatment of multiple sclerosis |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
-
2000
- 2000-06-02 DE DE60017733T patent/DE60017733T2/de not_active Expired - Lifetime
- 2000-06-02 WO PCT/IB2000/000933 patent/WO2000074676A1/en active IP Right Grant
- 2000-06-02 ES ES00939007T patent/ES2235896T3/es not_active Expired - Lifetime
- 2000-06-02 AT AT05001476T patent/ATE419851T1/de not_active IP Right Cessation
- 2000-06-02 JP JP2001501213A patent/JP2003522121A/ja active Pending
- 2000-06-02 SI SI200030601T patent/SI1187612T1/xx unknown
- 2000-06-02 PT PT00939007T patent/PT1187612E/pt unknown
- 2000-06-02 EP EP00939007A patent/EP1187612B1/de not_active Expired - Lifetime
- 2000-06-02 AT AT00939007T patent/ATE287713T1/de active
- 2000-06-02 CA CA002375874A patent/CA2375874A1/en not_active Abandoned
- 2000-06-02 EP EP05001476A patent/EP1552831B1/de not_active Expired - Lifetime
- 2000-06-02 AU AU54219/00A patent/AU777537B2/en not_active Ceased
- 2000-06-02 NZ NZ515685A patent/NZ515685A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1552831B1 (de) | 2009-01-07 |
| NZ515685A (en) | 2002-12-20 |
| AU777537B2 (en) | 2004-10-21 |
| DE60017733T2 (de) | 2006-01-12 |
| JP2003522121A (ja) | 2003-07-22 |
| WO2000074676A1 (en) | 2000-12-14 |
| EP1552831A1 (de) | 2005-07-13 |
| DE60017733D1 (de) | 2005-03-03 |
| EP1187612B1 (de) | 2005-01-26 |
| EP1187612A1 (de) | 2002-03-20 |
| ES2235896T3 (es) | 2005-07-16 |
| AU5421900A (en) | 2000-12-28 |
| CA2375874A1 (en) | 2000-12-14 |
| SI1187612T1 (en) | 2005-06-30 |
| PT1187612E (pt) | 2005-05-31 |
| ATE287713T1 (de) | 2005-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE313326T1 (de) | VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß | |
| ATE201138T1 (de) | Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose | |
| ATE480235T1 (de) | Verwendung von pramipexol zur behandlung von amyotrophischer lateralsklerose | |
| ATE304350T1 (de) | Probucol monoester zur behandlung von kreislauf- und entzündungserkrankungen | |
| ATE179610T1 (de) | Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten | |
| ZA200309808B (en) | Compositions and methods for the diagnosis and treatment of tumor | |
| DE60142590D1 (de) | Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen | |
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| ATE262895T1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| ATE362374T1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| ATE287713T1 (de) | Verwendung von riluzol zur behandlung multipler sklerose | |
| DE69937624D1 (de) | Verfahren zur Behandlung von Metalloberflächen | |
| DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
| ATE353667T1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE59705697D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
| DE60041365D1 (de) | Verwendung von Riluzol zur Behandlung Multipler Sklerose | |
| ATE281165T1 (de) | Verwendung von pramipexol zur behandlung von restless-legs-syndrom | |
| DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
| ATE208202T1 (de) | Verwendung von dimeticon zur behandlung der konstipation | |
| ATE226440T1 (de) | Zusammensetzung zur behandlung von psoriasis | |
| DE59904564D1 (de) | Verwendung von acetylcholinesterase-inhibitoren zur behandlung von delirien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |